Double minute amplification of mutant PDGF receptor α in a mouse glioma model

Hongyan Zou1, Rui Feng2, Yong Huang2

  • 11] Fishberg Department of Neuroscience, Friedman Brain Institute [2] Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Scientific Reports
|February 17, 2015
PubMed

Insights

Researchers created a mouse model for malignant glioma, revealing double minutes (DM) gene amplification of PDGF receptor alpha (PDGFRα) in oligodendrocyte precursor cells (OPCs) as an early event in brain tumor development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Oncogene amplification on extrachromosomal DNA as double minutes (DM) is common in primary brain tumors, but mechanisms are unclear.
  • Oligodendrocyte precursor cells (OPCs) are implicated in glioma development.

Purpose of the Study:

  • To generate a genetically defined mouse model for studying malignant glioma and double minutes (DM) gene amplification.
  • To investigate the role of PDGF receptor alpha (PDGFRα) signaling in gliomagenesis.

Main Methods:

  • Generated a knock-in mouse model with mutant PDGFRα in OPCs within an INK4/Arf(-/-) background.
  • Analyzed brain tumors and derived cell lines for gene amplification, including DM formation.
  • Characterized the cell of origin and the sequence of mutational events.

Main Results:

  • The mouse model frequently developed anaplastic gliomas (WHO grade III) and fibrosarcomas.
  • High prevalence of DM Pdgfra gene amplification was observed in brain tumors and cell lines.
  • Amplicons extended to neighboring genes Kit and Kdr in some cases.

Conclusions:

  • Oligodendrocyte precursor cells (OPCs) are a likely cell of origin for malignant gliomas.
  • PDGF receptor alpha (PDGFRα) gene amplification via double minutes (DM) is an early event in gliomagenesis.
  • This model provides insights into the mechanisms and functionality of DM gene amplification in brain tumor development.

Related Concept Videos